ResMed Pre-Tax Profit Margin 2010-2025 | RMD

Current and historical pre-tax profit margin for ResMed (RMD) from 2010 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. ResMed pre-tax profit margin for the three months ending March 31, 2025 was .
ResMed Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2025-03-31 $5.02B $1.58B 31.40%
2024-12-31 $4.93B $1.53B 31.13%
2024-09-30 $4.81B $1.38B 28.60%
2024-06-30 $4.69B $1.26B 26.98%
2024-03-31 $4.58B $1.18B 25.81%
2023-12-31 $4.50B $1.10B 24.36%
2023-09-30 $4.38B $1.11B 25.42%
2023-06-30 $4.22B $1.10B 26.10%
2023-03-31 $4.02B $1.06B 26.47%
2022-12-31 $3.76B $1.00B 26.57%
2022-09-30 $3.63B $0.96B 26.57%
2022-06-30 $3.58B $0.96B 26.82%
2022-03-31 $3.54B $0.96B 27.15%
2021-12-31 $3.44B $0.95B 27.67%
2021-09-30 $3.35B $0.93B 27.68%
2021-06-30 $3.20B $0.88B 27.65%
2021-03-31 $3.09B $0.86B 27.73%
2020-12-31 $3.09B $0.83B 26.88%
2020-09-30 $3.03B $0.80B 26.40%
2020-06-30 $2.96B $0.73B 24.83%
2020-03-31 $2.89B $0.62B 21.38%
2019-12-31 $2.78B $0.56B 20.26%
2019-09-30 $2.70B $0.53B 19.67%
2019-06-30 $2.61B $0.52B 19.92%
2019-03-31 $2.53B $0.56B 22.34%
2018-12-31 $2.46B $0.56B 22.65%
2018-09-30 $2.41B $0.55B 22.95%
2018-06-30 $2.34B $0.52B 22.26%
2018-03-31 $2.27B $0.50B 22.08%
2017-12-31 $2.20B $0.48B 21.86%
2017-09-30 $2.13B $0.43B 20.42%
2017-06-30 $2.07B $0.42B 20.28%
2017-03-31 $2.03B $0.41B 20.41%
2016-12-31 $1.97B $0.42B 21.09%
2016-09-30 $1.89B $0.43B 22.87%
2016-06-30 $1.84B $0.44B 23.86%
2016-03-31 $1.77B $0.43B 24.01%
2015-12-31 $1.74B $0.43B 24.74%
2015-09-30 $1.71B $0.43B 25.32%
2015-06-30 $1.68B $0.44B 25.98%
2015-03-31 $1.64B $0.44B 26.77%
2014-12-31 $1.62B $0.44B 27.10%
2014-09-30 $1.58B $0.43B 27.33%
2014-06-30 $1.56B $0.43B 27.72%
2014-03-31 $1.56B $0.41B 26.50%
2013-12-31 $1.54B $0.41B 26.41%
2013-09-30 $1.53B $0.40B 25.81%
2013-06-30 $1.52B $0.39B 25.40%
2013-03-31 $1.47B $0.40B 26.88%
2012-12-31 $1.44B $0.37B 25.87%
2012-09-30 $1.39B $0.36B 25.61%
2012-06-30 $1.37B $0.33B 24.25%
2012-03-31 $1.34B $0.31B 23.15%
2011-12-31 $1.30B $0.30B 22.79%
2011-09-30 $1.28B $0.29B 22.96%
2011-06-30 $1.24B $0.30B 24.46%
2011-03-31 $1.19B $0.30B 25.06%
2010-12-31 $1.16B $0.30B 25.54%
2010-09-30 $1.13B $0.28B 24.82%
2010-06-30 $1.09B $0.26B 23.88%
2010-03-31 $1.05B $0.25B 23.84%
2009-12-31 $1.00B $0.24B 23.65%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $37.523B $4.685B
ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $240.237B 28.89
Boston Scientific (BSX) United States $154.040B 38.56
Stryker (SYK) United States $147.507B 30.84
EssilorLuxottica (ESLOY) France $130.320B 0.00
Medtronic (MDT) Ireland $110.401B 15.65
Lonza Group Ag (LZAGY) Switzerland $51.194B 0.00
Haleon (HLN) United Kingdom $47.171B 26.90
Agilent Technologies (A) United States $33.417B 21.78
GE HealthCare Technologies (GEHC) United States $32.959B 15.65
Terumo (TRUMY) Japan $27.294B 35.45
Koninklijke Philips (PHG) Netherlands $23.014B 16.15
Insulet (PODD) United States $21.880B 85.88
Zimmer Biomet Holdings (ZBH) United States $18.269B 11.73
Baxter (BAX) United States $15.698B 11.72
Smith & Nephew SNATS (SNN) United Kingdom $13.073B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.474B 22.53
Lantheus Holdings (LNTH) United States $5.601B 14.13
Prestige Consumer Healthcare (PBH) United States $4.184B 18.69
Perrigo (PRGO) Ireland $3.678B 9.32
Haemonetics (HAE) United States $3.510B 15.99
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.221B 23.75
Envista Holdings (NVST) United States $3.210B 26.68
GN Store Nord (GNNDY) Denmark $2.346B 19.43
QuidelOrtho (QDEL) United States $1.939B 13.34
LeMaitre Vascular (LMAT) United States $1.916B 42.83
AtriCure (ATRC) United States $1.621B 0.00
Acuren (TIC) United States $1.311B 0.00
AdaptHealth (AHCO) United States $1.182B 12.00
Neogen (NEOG) United States $1.070B 13.69
Green Thumb Industries (GTBIF) United States $1.063B 23.91
BioLife Solutions (BLFS) United States $1.036B 0.00
Phibro Animal Health (PAHC) United States $1.004B 12.83
Kestra Medical Technologies (KMTS) United States $0.906B 0.00
InMode (INMD) Israel $0.870B 8.76
CeriBell (CBLL) United States $0.710B 0.00
Evolus (EOLS) United States $0.620B 0.00
Owens & Minor (OMI) United States $0.578B 4.79
Maravai LifeSciences Holdings (MRVI) United States $0.568B 0.00
Curaleaf Holdings (CURLF) Canada $0.519B 0.00
Valneva SE (VALN) France $0.477B 0.00
Capricor Therapeutics (CAPR) United States $0.423B 0.00
Surmodics (SRDX) United States $0.415B 0.00
Tilray Brands (TLRY) Canada $0.384B 0.00
VAREX IMAGING (VREX) United States $0.328B 12.05
SNDL (SNDL) Canada $0.326B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.300B 0.00
Sanuwave Health (SNWV) United States $0.279B 0.00
Viemed Healthcare (VMD) United States $0.274B 23.10
Cerus (CERS) United States $0.262B 0.00
Sanara MedTech (SMTI) United States $0.253B 0.00
ZimVie (ZIMV) United States $0.247B 11.22
Brainsway (BWAY) Israel $0.232B 61.30
Canopy Growth (CGC) Canada $0.230B 0.00
Quanterix (QTRX) United States $0.229B 0.00
Cresco Labs (CRLBF) United States $0.228B 0.00
OraSure Technologies (OSUR) United States $0.224B 0.00
Aurora Cannabis (ACB) Canada $0.224B 66.33
Biote (BTMD) United States $0.218B 6.14
Omeros (OMER) United States $0.198B 0.00
TriSalus Life Sciences (TLSI) United States $0.198B 0.00
Organigram Global (OGI) Canada $0.182B 0.00
Utah Medical Products (UTMD) United States $0.181B 14.74
High Tide (HITI) Canada $0.177B 0.00
Verano Holdings (VRNOF) United States $0.175B 0.00
Exagen (XGN) United States $0.150B 0.00
Vireo Growth (VREOF) United States $0.131B 0.00
FitLife Brands (FTLF) United States $0.121B 14.84
Jin Medical (ZJYL) China $0.103B 0.00
Veru (VERU) United States $0.098B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.089B 0.00
Fonar (FONR) United States $0.088B 11.32
Apyx Medical (APYX) United States $0.086B 0.00
Quipt Home Medical (QIPT) United States $0.086B 0.00
MacroGenics (MGNX) United States $0.085B 0.00
TerrAscend (TSNDF) Canada $0.078B 0.00
Zynex (ZYXI) United States $0.076B 0.00
Cytosorbents (CTSO) United States $0.075B 0.00
InterCure (INCR) Israel $0.069B 0.00
Agape ATP (ATPC) $0.065B 0.00
ImmuCell (ICCC) United States $0.062B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
Nephros (NEPH) United States $0.044B 59.43
Modular Medical (MODD) United States $0.043B 0.00
United-Guardian (UG) United States $0.037B 12.89
Rockwell Medical (RMTI) United States $0.030B 0.00
Safety Shot (SHOT) United States $0.023B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
Cellectar Biosciences (CLRB) United States $0.018B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
INLIF (INLF) $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Senestech (SNES) United States $0.007B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00